Article
Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.
The Journal of biological chemistry - 11 Nov 2005
Bohl Casey E, Miller Duane D, Chen Jiyun, Bell Charles E, Dalton James T
Abstract excerpt
The mechanism by which the androgen receptor (AR) distinguishes between agonist and antagonist ligands is poorly understood. AR antagonists are currently used to treat prostate cancer. However, mutations commonly develop in patients that convert these compounds to agonists. Recently, our laboratory discovered selective androgen receptor modulators, which structurally resemble the nonsteroidal AR antagonists...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
